These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25241943)

  • 1. Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length.
    Park WJ; Park JW; Merrill AH; Storch J; Pewzner-Jung Y; Futerman AH
    Biochim Biophys Acta; 2014 Dec; 1841(12):1754-66. PubMed ID: 25241943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization.
    Park WJ; Park JW; Erez-Roman R; Kogot-Levin A; Bame JR; Tirosh B; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH
    J Biol Chem; 2013 Oct; 288(43):30904-16. PubMed ID: 24019516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes.
    Park JW; Park WJ; Kuperman Y; Boura-Halfon S; Pewzner-Jung Y; Futerman AH
    Hepatology; 2013 Feb; 57(2):525-32. PubMed ID: 22911490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.
    Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA
    Cell Metab; 2014 Oct; 20(4):687-95. PubMed ID: 25295789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization.
    Ali M; Fritsch J; Zigdon H; Pewzner-Jung Y; Schütze S; Futerman AH
    Cell Death Dis; 2013 Nov; 4(11):e929. PubMed ID: 24263103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle.
    Nickerson JG; Alkhateeb H; Benton CR; Lally J; Nickerson J; Han XX; Wilson MH; Jain SS; Snook LA; Glatz JFC; Chabowski A; Luiken JJFP; Bonen A
    J Biol Chem; 2009 Jun; 284(24):16522-16530. PubMed ID: 19380575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases.
    Kim YR; Lee EJ; Shin KO; Kim MH; Pewzner-Jung Y; Lee YM; Park JW; Futerman AH; Park WJ
    Exp Mol Med; 2019 Nov; 51(11):1-16. PubMed ID: 31676768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
    Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
    Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain.
    Zigdon H; Kogot-Levin A; Park JW; Goldschmidt R; Kelly S; Merrill AH; Scherz A; Pewzner-Jung Y; Saada A; Futerman AH
    J Biol Chem; 2013 Feb; 288(7):4947-56. PubMed ID: 23283968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress elicited by modifying the ceramide acyl chain length reduces the rate of clathrin-mediated endocytosis.
    Volpert G; Ben-Dor S; Tarcic O; Duan J; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH
    J Cell Sci; 2017 Apr; 130(8):1486-1493. PubMed ID: 28280117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
    Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
    J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.
    Kasbi-Chadli F; Ferchaud-Roucher V; Krempf M; Ouguerram K
    Eur J Nutr; 2016 Mar; 55(2):589-599. PubMed ID: 25787885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle.
    Han XX; Chabowski A; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E566-75. PubMed ID: 17519284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread tissue distribution and synthetic pathway of polyunsaturated C24:2 sphingolipids in mammals.
    Edagawa M; Sawai M; Ohno Y; Kihara A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1441-1448. PubMed ID: 30251650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering sphingolipid composition with aging induces contractile dysfunction of gastric smooth muscle via K(Ca) 1.1 upregulation.
    Choi S; Kim JA; Kim TH; Li HY; Shin KO; Lee YM; Oh S; Pewzner-Jung Y; Futerman AH; Suh SH
    Aging Cell; 2015 Dec; 14(6):982-94. PubMed ID: 26288989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.
    Imgrund S; Hartmann D; Farwanah H; Eckhardt M; Sandhoff R; Degen J; Gieselmann V; Sandhoff K; Willecke K
    J Biol Chem; 2009 Nov; 284(48):33549-60. PubMed ID: 19801672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.
    Lee JH; Wada T; Febbraio M; He J; Matsubara T; Lee MJ; Gonzalez FJ; Xie W
    Gastroenterology; 2010 Aug; 139(2):653-63. PubMed ID: 20303349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
    Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice.
    McIntosh AL; Atshaves BP; Landrock D; Landrock KK; Martin GG; Storey SM; Kier AB; Schroeder F
    Lipids; 2013 May; 48(5):435-48. PubMed ID: 23539345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane.
    Chabowski A; Górski J; Luiken JJ; Glatz JF; Bonen A
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):345-53. PubMed ID: 18240411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.